Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review

  • ID: 4282133
  • SWOT Analysis
  • 44 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Dare Bioscience Inc
  • Eloxx Pharmaceuticals Inc
  • GT Biopharma Inc
  • Idera Pharmaceuticals Inc
  • MORE
Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidates. Its immuno-oncology product candidates include adaptive NK, pluripotent cell-derived cancer immunotherapies, and engineered CAR and TCR T- cell immunotherapies. Its products are derived from pluripotent cells. Fate Therapeutics uses ex vivo cell programming approach to include cell-surface proteins, rapid and supra-physiologic activation or inhibition of therapeutically-relevant genes, and to regulate the therapeutic function. The company’s immuno-regulatory cellular therapies promote immune system homeostasis for patients undergoing hematopoietic cell transplantation and immune disorders. Fate Therapeutics is headquartered in San Diego, California, the US.

Fate Therapeutics Inc Key Recent Developments

Nov 01, 2017: Fate Therapeutics Reports Third Quarter 2017 Financial Results
Sep 14, 2017: Fate Therapeutics Appoints Jim Beitel as Senior Vice President, Corporate Development
Aug 14, 2017: Fate Therapeutics Reports Second Quarter 2017 Financial Results
May 15, 2017: Fate Therapeutics Reports First Quarter 2017 Financial Results
Mar 16, 2017: Fate Therapeutics Reports Fourth Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Dare Bioscience Inc
  • Eloxx Pharmaceuticals Inc
  • GT Biopharma Inc
  • Idera Pharmaceuticals Inc
  • MORE
Section 1 - About the Company
  • Fate Therapeutics Inc - Key Facts
  • Fate Therapeutics Inc - Key Employees
  • Fate Therapeutics Inc - Key Employee Biographies
  • Fate Therapeutics Inc - Major Products and Services
  • Fate Therapeutics Inc - History
  • Fate Therapeutics Inc - Company Statement
  • Fate Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Fate Therapeutics Inc - Business Description
  • R&D Overview
  • Fate Therapeutics Inc - Corporate Strategy
  • Fate Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Fate Therapeutics Inc - Strengths
  • Fate Therapeutics Inc - Weaknesses
  • Fate Therapeutics Inc - Opportunities
  • Fate Therapeutics Inc - Threats
  • Fate Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Fate Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 01, 2017: Fate Therapeutics Reports Third Quarter 2017 Financial Results
  • Sep 14, 2017: Fate Therapeutics Appoints Jim Beitel as Senior Vice President, Corporate Development
  • Aug 14, 2017: Fate Therapeutics Reports Second Quarter 2017 Financial Results
  • May 15, 2017: Fate Therapeutics Reports First Quarter 2017 Financial Results
  • Mar 16, 2017: Fate Therapeutics Reports Fourth Quarter 2016 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Fate Therapeutics Inc, Key Facts
  • Fate Therapeutics Inc, Key Employees
  • Fate Therapeutics Inc, Key Employee Biographies
  • Fate Therapeutics Inc, Major Products and Services
  • Fate Therapeutics Inc, History
  • Fate Therapeutics Inc, Subsidiaries
  • Fate Therapeutics Inc, Key Competitors
  • Fate Therapeutics Inc, Ratios based on current share price
  • Fate Therapeutics Inc, Annual Ratios
  • Fate Therapeutics Inc, Annual Ratios
  • Fate Therapeutics Inc, Interim Ratios
  • Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Fate Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Fate Therapeutics Inc, Performance Chart (2012 - 2016)
  • Fate Therapeutics Inc, Ratio Charts
  • Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Idera Pharmaceuticals Inc
  • GT Biopharma Inc
  • Eloxx Pharmaceuticals Inc
  • Dare Bioscience Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll